Established more than three decades ago, Kamada is a global biopharmaceutical company focused on developing and distributing innovative specialty-plasma therapies to save and improve lives worldwide.
In the U.S., we commercially operate through a wholly owned subsidiary, Kamada Inc., which supports healthcare professionals and patients by offering a broad range of hyperimmune plasma therapies that provide passive immunity to a wide range of infectious agents.
Kamada Inc. focuses on areas of high unmet medical need, including transplantation, infectious disease, and hematology.
Products distributed by Kamada in the U.S.: